0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
Abstract Background Intravenous fluid therapy represents the most common intervention critically ill patients are exposed to. Hyperchloremia and metabolic acidosis associated with 0.9% sodium chloride have been observed to lead to worse outcomes, including mortality. Balanced solutions, such as Plas...
Main Authors: | Sainath Raman, Andreas Schibler, Renate Le Marsney, Peter Trnka, Melanie Kennedy, Adrian Mattke, Kristen Gibbons, Luregn J. Schlapbach |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05376-5 |
Similar Items
-
Low-Dose Intravenous Ketamine Bolus versus Conventional Technique for the Reduction of Upper and Lower Extremity Fractures in Children: A Randomised Controlled Clinical Trial
by: Mehdi Nasr Isfahani, et al.
Published: (2020-09-01) -
A randomized controlled trial of 3 IU Intravenous oxytocin bolus with 7 IU oxytocin infusion versus 10 IU oxytocin intramuscular in the third stage of labor for the prevention of postpartum hemorrhage
by: Shivakumar Pujeri
Published: (2020-01-01) -
Cap-Assisted Technique versus Conventional Methods for Esophageal Food Bolus Extraction: A Comparative Study
by: Mahmoud Wahba, et al.
Published: (2019-09-01) -
Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs
by: Sophie Hammond, et al.
Published: (2020-06-01) -
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
by: Torre E, et al.
Published: (2018-07-01)